Head-to-head · WeighScore
Elara MD vs MEDVidi
The verdict
MEDVidi takes it — 58/100 to 53.5/100.
MEDVidi grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. MEDVidi is a US telehealth platform whose licensed providers evaluate patients and prescribe GLP-1 weight-management medications, including brand-name Zepbound (tirzepatide) and Wegovy (semaglutide), plus…
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Elara MD | MEDVidi |
|---|---|---|
| WeighScore | 53.5/100 | 58/100 |
| Grade | C | C |
| Scorecard rank | #466 | #384 |
| Semaglutide | $249/mo (0.2 mg dose, compounded) | Not disclosed |
| Tirzepatide | $349/mo (2.0 mg dose, compounded) | Not disclosed |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | Injection only | Injection only |
Graded #466 · C
Strengths
- Dose-banded monthly pricing published on-site ($249–$649/mo across tiers)
- Both a semaglutide-range and a tirzepatide-range (GLP-1/GIP) option, plus microdosing
- Medication included in the monthly price with free fast shipping when prescribed
- Broad reach claimed (over 40 states)
Where it loses points
- Molecules not named on-site (only 'Personalized GLP-1') — compounded status is inferred
- No FDA compounded-medication disclaimer published
- No named compounding pharmacy partner — prescriptions are patient-directed
- LegitScript certification, medical director, and full state list not disclosed
- Pricier than several compounded competitors
Graded #384 · C
Strengths
- Licensed providers can prescribe brand-name Zepbound and Wegovy
- Transparent flat consultation fees (195 dollar initial, 159 dollar follow-up)
- Prescriptions sent to the patient's pharmacy of choice, so insurance can be used
Where it loses points
- Consult-fee model: medication is not included and its cost is separate
- No medication pricing is published
- State list is shown as a map rather than enumerated
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.